Bioactive by-products
| Catalog | Product Name / CAS / Description | Structure |
|---|---|---|
| BBF-01458 | ||
It is produced by the strain of Talararomyces flavus FKI-0076. Deoxyfunicone is an antifungal activity enhancer of Miconazole. |
||
| BBF-01467 | ||
Fusarin C is produced by the strain of Fusarium moniliforrme which has mutagenicity. |
||
| BBF-01476 |
Galbonolide A (100227-57-4) Inquiry |
|
Galbonolide A is originally isolated from Micromonospora chalcea. It is a 14-membered macrolide identified as an inhibitor of plant pathogenic fungi. |
||
| BBF-01477 |
Galbonolide B (100157-26-4) Inquiry |
|
Galbonolide B is originally isolated from Micromonospora chalcea. It is a 14-membered macrolide identified as an inhibitor of plant pathogenic fungi. |
||
| BBF-01479 |
Ganoderic acid U (86377-51-7) Inquiry |
|
Ganoderic acid U is a substance isolated from Ganoderma lucidum with anti-tumor activity. |
||
| BBF-01480 |
Ganoderic acid W (86377-49-3) Inquiry |
|
Ganoderic acid W is a substance isolated from Ganoderma lucidum with anti-tumor activity. |
||
| BBF-01481 |
Ganoderic acid X (86377-53-9) Inquiry |
|
Ganoderic acid X is a substance isolated from Ganoderma lucidum with anti-tumor activity. |
||
| BBF-01485 |
Hynapene A (155111-89-0) Inquiry |
|
Hynapene A is produced by the strain of Penicillum sp. FO-1611. The MIC (X 10-6 mol/L) for Eimeria tenella inhibition is 123. |
||
| BBF-01486 |
Hynapene B (155111-88-9) Inquiry |
|
Hynapene B is produced by the strain of Penicillum sp. FO-1611. The MIC (X 10-6 mol/L) for Eimeria tenella inhibition is 34.7. |
||
| BBF-01487 |
Hynapene C (155111-90-3) Inquiry |
|
Hynapene C is produced by the strain of Penicillum sp. FO-1611. The MIC (X 10-6 mol/L) for Eimeria tenella inhibition is 34.7. |
||
| BBF-01520 | ||
It inhibited K-562 proliferation of chronic myeloid leukemia cells with Gl50 of 1.9 μg/mL. |
||
| BBF-01577 | ||
U-68204 is a thiolactone-containing metabolite produced by a soil actinomycete identified as Streptomyces thiolactonus UC 8478 (NRRL 15,439). It exhibited mild antibacterial activity with CD50 of 50mg/kg for inhibition of bacillus influenzae. |
||
| BBF-01578 | ||
Paulomycin A is a metabolite produced by Streptomyces paulus strain 273. It exhibits mild activity against gram-positive bacteria. |
||
| BBF-01579 | ||
Paulomycin B is a metabolite produced by Streptomyces paulus strain 273. It exhibits mild activity against gram-positive bacteria. |
||
| BBF-01589 | ||
UCF116-C is a metabolite produced by Steptomyces sp. It is inactive for Ftase. |
||
| BBF-01597 | ||
UK-2A is produced by Streptomyces sp. 517-02. Its antifungal effect is similar to that of Antimycin A3. |
||
| BBF-01598 | ||
UK-2B is produced by Streptomyces sp. 517-02. Its antifungal effect is similar to that of Antimycin A3. |
||
| BBF-01599 | ||
UK-2C is produced by Streptomyces sp. 517-02. Its antifungal effect is similar to that of Antimycin A3. |
||
| BBF-01600 | ||
UK-2D is produced by Streptomyces sp. 517-02. Its antifungal effect is similar to that of Antimycin A3. |
||
| BBF-01604 | ||
UK-63052 is one antibiotic of UK-63052 complex, which is produced by Streptomyces braegensis subsp. Japonicus. It is effective against some gram-positive bacteria including Staphylococcus aureus. |
